[1]
R. Yoncón Romero and G. Ochoa Alarcón, “Tumor infiltrating lymphocyte grade as prognostic factor of recurrence in molecular subtypes of breast cancer (triple negative and Her2): Narrative Review”, Rev. Oncol. Ecu., vol. 32, no. 1, pp. 71–85, Apr. 2022.